Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Apolipoproteins A measurement

Known as: APOA, Apolipoprotein A, Apo A Measurement 
The determination of the amount of apolipoprotein A present in a sample.
National Institutes of Health

Related topics

Related topics

5 relations
Apolipoproteins AApoprotein(a)CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by Name
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.
OBJECTIVES This study was designed to assess the relationship of high-density-lipoprotein cholesterol (HDL-C), HDL particle size… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study.
OBJECTIVES The aim of this study was to determine whether apolipoproteins (apo) B and A-I measured in childhood and adolescence… Expand
  • table 1
  • table 3
  • table 2
  • figure 1
  • table 5
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Adiponectin Is an Important Determinant of ApoA-I Catabolism
Objective—Plasma concentration of adiponectin is positively correlated with high-density lipoprotein (HDL) cholesterol level… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease.
OBJECTIVES We investigated the consequences of an apolipoprotein A-I (apoA-I) gene defect with regard to lipid metabolism… Expand
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome.
The metabolism of apolipoproteins (apo)B-48, B-100, and A-I was studied with a primed constant infusion of deuterium-labeled… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Impact of myristic acid versus palmitic acid on serum lipid and lipoprotein levels in healthy women and men.
The cholesterol-raising effect of dietary saturated fatty acids is largely accounted for by lauric, myristic, and palmitic acids… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study.
A decreased high density lipoprotein (HDL) cholesterol level (< 35 mg/dl) has been shown to be a significant independent risk… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
Classic (complete) lecithin:cholesterol acyltransferase (LCAT) deficiency and Fish-eye disease (partial LCAT deficiency) are… Expand
  • table I
  • table II
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
1992
Highly Cited
1992
In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis.
Apolipoprotein (apo) A-I is the major protein constituent of plasma high density lipoproteins (HDL). A kindred has been… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
To study the effect of renal function on the development of lipid and apolipoprotein abnormalities in human renal disease, we… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE